Protocol for CRISPR-Cas9-mediated induction of KMT2A rearrangements in cell line and umbilical cord blood hematopoietic stem and progenitor cells
T Benz, Patrizia Larghero, Claus Meyer, Marcel A. Müller et autres
2 citationsSTAR Protocols
Claus Meyer
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
274Publications signalées
6169Citations signalées
1Affiliations récentes
Institutions déclarées
Domaines associés
Acute Myeloid Leukemia ResearchAcute Lymphoblastic Leukemia researchChronic Myeloid Leukemia TreatmentsChronic Lymphocytic Leukemia ResearchProtein Degradation and Inhibitors
Publications récentes
Prenatal origin of NUTM1 gene rearrangement in infant B‐cell precursor acute lymphoblastic leukaemia
Michela Bardini, Grazia Fazio, L Corral Abascal, Claus Meyer et autres
6 citationsBritish Journal of Haematology
Distinct pattern of genomic breakpoints in CML and BCR::ABL1-positive ALL: analysis of 971 patients
Lenka Hovorková, Lucie Winkowska, Justina Skorepova, Manuela Krumbholz et autres
9 citationsMolecular Cancer
Measurable residual disease quantification in adult patients with KMT2A-rearranged acute lymphoblastic leukemia
Thomas Burmeister, Aeint-Steffen Ströh, Britta Kehden, Heiko Trautmann et autres
8 citationsLeukemia
Genomic DNA-based measurable residual disease monitoring in pediatric acute myeloid leukemia: unselected consecutive cohort study
Markéta Žaliová, Jan Zuna, Lucie Winkowska, Iveta Janotová et autres
10 citationsLeukemia
Distinct Pattern of ABL1 Genomic Breakpoints in Chronic Myeloid Leukemia and BCR::ABL1-Positive Acute Lymphoblastic Leukemia: Analysis of 884 Patients with Minor and Major BCR::ABL1 Fusion
Lenka Hovorková, Lucie Winkowska, Justina Krotka, Manuela Krumbholz et autres
1 citationBlood
Independent Prognostic Value of DNA-Based Minimal Residual Disease Assessment in Unselected Population-Based Cohort of Pediatric Acute Myeloid Leukemia
Markéta Žaliová, Jan Zuna, Lucie Winkowska, Iveta Janotová et autres
0 citationsBlood
A human genome editing–based MLL::AF4 ALL model recapitulates key cellular and molecular leukemogenic features
Clara Bueno, Raúl Torres, Talía Velasco-Hernández, Òscar Molina et autres
8 citationsBlood
Genetic alterations and MRD refine risk assessment for KMT2A -rearranged B-cell precursor ALL in adults: a GRAALL study
Rathana Kim, Hugo Bergugnat, Cédric Pastoret, Florence Pasquier et autres
33 citationsBlood
P315: TP53 ALTERATIONS AND MRD REFINE PROGNOSIS OF ADULT KMT2A-REARRANGED B-ALL
Rathana Kim, Hugo Bergugnat, Florence Pasquier, Emmanuel Raffoux et autres
0 citationsHemaSphere
P337: IKZF1 DELETIONS IN B-ALL: FROM ITS GENETIC BASIS TO DIAGNOSTIC ENHANCEMENT
Bruno A. Lopes, Claus Meyer, Heloysa Bouzada, Marius Külp et autres
0 citationsHemaSphere
A human genome editing-based MLL-AF4 acute lymphoblastic leukemia model recapitulates key cellular and molecular leukemogenic features. (Processed data)
Clara Bueno, Raúl Torres, Òscar Molina, Paolo Petazzi et autres
0 citationsZenodo (CERN European Organization for Nuclear Research)
BNTIC News n’est pas le producteur de ces données. Métadonnées interrogées à la demande auprès de OpenAlex (CC0). Sources et limites.